公司资料
Livongo 股价、新闻与催化剂
- 股票代码:
- LVGO
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
目前无法获取 LVGO 的收盘价变动背景。
公司概览
业务概览
Livongo was a digital health company focused on chronic disease management, remote monitoring, and data-driven behavior change before being acquired by Teladoc Health. Its core identity was built around applied health signals for diabetes and other chronic conditions.
所在地与行业分类
Livongo was headquartered in the United States and traded on NASDAQ before the merger closed. It sat in digital health rather than therapeutic biotechnology.
商业模式特征
The company generated value through subscription-style digital health services, data platforms, and chronic-care engagement. Investors historically watched member growth, platform adoption, and the scalability of its virtual care model.
生物医药行业定位
Livongo was not a biotech company, but it was relevant to the healthcare innovation stack because it influenced chronic-care access and monitoring. Since it was acquired, it now belongs to the historical digital-health category.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。